- Article
- Published:
Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princes on rat lens aldose reductase and on the formation of advanced glycation end products
Journal of the Korean Society for Applied Biological Chemistry volume 52, pages 655–662 (2009)
Abstract
Caffeoylquinic acids -3,4-di-O-caffeoylquinic acid (1); 1,3,5-tri-O-caffeoylquinic acid (2); and 3,4,5-tri-O-caffeoylqunic acid (3)- were isolated from an acetone-soluble fraction of the aerial parts of Artemisia princes. Their structures were determined spectroscopically using 1D- and 2D-nuclear magnetic resonance (NMR) studies, as well as by comparing the NMR results with previously published structures. All the isolates were subjected to in vitro bioassays to evaluate their efficacy in inhibiting rat lens aldose reductase (RLAR) activity and the formation of advanced glycation end products (AGEs). We found 1,3,5-tri-O-caffeoylquinic acid (2) to be the most potent AGE inhibitor, and the concentration that resulted in 50% inhibition (IC50) was 22.18 ±1.46 mM, as compared to the aminoguanidine and chlorogenic acid controls, which had IC50 values of 1,093.11±10.95 and 117.63±0.20 mM, respectively. In the RLAR assay, the three caffeoylquinic acids were found to have IC50 values in the range of 1.78-2.40 μM, demonstrating a 5- to 10-fold greater efficacy in RLAR inhibition as compared to the quercetin control, which had an IC50 value of 17.91 μM.
Abbreviations
- AGEs:
-
advanced glycation end products
- A. princeps:
-
Artemisia princes
- AR:
-
aldose reductase
- BSA-MGO:
-
methylglyoxal-modified bovine serum albumin
- ESI-MS:
-
electron spray ionization-mass spectrophotometer
- HMBC:
-
heteronuclear multiple bond coherence
- HMQC:
-
heteronuclear multiple quantum coherence
- IC50 :
-
half maximal inhibitory concentration
- MGO:
-
methylglyoxal
- NADPH:
-
nicotinamide adenine dinucleotide phosphate
- NMR:
-
nuclear magnetic resonance
- RLAR:
-
rat lens aldose reductase
- SD:
-
Sprague-Dawley
References
Agata I, Goto S, Hatano T, Nishibe S, and Okuda T (1993) 1,3,5-Tri-O-caffeoylquinic acid from Xanthium strumarium. Phytochemistry 33, 508–509.
Ahmed N (2005) Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract 67, 3–21.
Alexiou P, Pegklidou K, Chatzopoulou M, Nicolaou I, and Demopoulos VJ (2009) Aldose reductase enzyme and its implication to major health problems of the 21(st) century. Curr Med Chem 16, 734–752.
AI-Waili NS (1986) Treatment of diabetes mellitus by Artemisia herba-alba extract: Preliminary study. Clin Exp Pharmacol Physiol 13, 569–673.
Basnet P, Matsushige K, Hase K, Kadota S, and Namba T (1996) Four di-O-caffeoyl quinic acid derivatives from propolis. Potent hepatoprotective activity in experimental liver injury models. Biol Pharm Bull 19, 1479–1484.
Bang MH, Han MW, Song MC, Cho JG, Chung HG, Jeong TS, Lee KT, Choi MS, Kim SY, and Baek NI (2008) A cytotoxic and apoptosis-inducing sesquiterpenoid isolated from the aerial parts of Artemisia Princeps PAMPANINI (Sajabalssuk). Chem Pharm Bull 56, 1168–1162.
Brownlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813–820.
Chang SH, Jung EJ, Park YH, Lim DG, Ko NY, Choi WS, Her E, Kim SH, Choi KD, Bae JH, Kim SH, Kang CD, Han DJ, and Kim SC (2009) Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cell and regulatory T cells. J Pharm Pharmacol 61, 1043–1050.
Chung SS and Chung SK (2005) Aldose reductase in diabetic microvascular complications. Curr Drug Targets 6, 475–486.
DeFronzo RA (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5, 177–269.
Fuente JÁ and Manzanaro S (2003) Aldose reductase inhibitors from natural sources. Nat Prod Rep 20, 243–251
Han JM, Kim MJ, Baek SH, An S, Jin YY, Chung HG, Baek NI, Choi MS, Lee KT, and Jeong TS (2009) Anti-atherosclerotic effects of Artemisia princes Pampanini cv. Sajabal in LDL receptor deficient mice. J Agric Food Chem 57, 1267–1274.
Hayman S and Kinoshita JH (1965) Isolation and Properties of Lens Aldose Reductase. J Biol Chem 240, 877–882.
Hung TM, Na M, Thuong PT, Su ND, Sok D, Song KS, Seong YH, and Bae K (2006) Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall. J Ethnopharmacol 108, 188–192.
Jung UJ, Baek NI, Chung HG, Bang MH, Yoo JS, Jeong TS, Lee KT, Kang YJ, Lee MK, Kim HJ, Yeo JY, and Choi MS (2007) The anti-diabetic effects of ethanol extract from two variants of Artemisia princes Pampanini in C57BL/KsJ-db/db mice. Food Chem Toxicol 45, 2022–2029.
Kang YJ, Jung UJ, Lee MK, Kim HJ, Jeon SM, Park YB, Chung HG, Baek NI, Lee KT, Jeong TS, and Choi MS (2008) Eupatilin, isolated from Artemisia princes Pampanini, enhances hepatic glucose metabolism and pancreatic beta-cell function in type 2 diabetic mice. Diabetes Res Clin Pract 82, 25–32.
Kim MJ, Han JM, Jin YY, Baek NI, Bang MH, Chung HG, Choi MS, Lee KT, Sok DE, and Jeong TS (2008) In Vitro antioxidant and anti-inflammatory activities of Jaceosidin from Artemisia princes Pampanini cv. Sajabal. Arch Pharm Res 31, 429–437.
Lee SO, Jeong JY, Kim M, Kim CH, and Lee IS (2008a) Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem Biophys Res Commun 366, 1019–1024.
Lee YS, Kang YH, Jung JY, Lee S, Ohuchi K, Shin KH, Kang IJ, Park JH, Shin HK, and Lim SS (2008b) Protein glycation inhibitors from the fruiting body of Phellinus linteus. Biol Pharm Bull 31, 1968–1972.
Lee YS, Kang YH, Jung JY, Kang IJ, Han SN, Chung JS, Shin HK, and Lim SS (2008c) Inhibitory constituents of aldose reductase in the fruiting body of Phellinus linteus. Biol Pharm Bull 31, 765–758.
Li Y, But PP, and Ooi VE (2005) Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.). Frodin Antiviral Res 68, 1–9.
Logendra S, Ribnicky DM, Yang H, Poulev A, Ma J, Kennelly EJ, and Raskin I (2006) Bioassay-guided isolation of aldose reductase inhibitors from Artemisia dracunculus. Phytochemistry 67, 1539–1546.
McArthur ED (1979) Sagebrush systemic and evolution. In Sagebrush Ecosystem Symposium, pp. 14–22. Utah State University, Logan, UT, U.S.A.
Merfort I (1992) Caffeoylquinic acids from flowers of Arnica Montana and Arnica chamissonis. Phytochemistry 31, 2111–2113.
Nakatani N, Kayano S, Kikuzaki H, Sumino K, Katagiri K, and Mitani T (2000) Identification, quantitative determination, and antioxidative activities of chlorogenic acid isomers in prune (Prunus domestica L.). J Agric Food Chem 48, 5512–5516.
Nguyen MT, Awale S, Tezuka Y, Ueda JY, Tran Q, and Kadota S (2006) Xanthine oxidase inhibitors from the flowers of Chrysanthemum sinensis. Planta Med 72, 46–51.
Okada Y, Miyauchi N, Suzuki K, Kobayashi T, Tsutsui C, Mayuzumi K, Nishibe S, and Okuyama T (1995) Search for naturally occurring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation. Chem Pharm Bull 43, 1385–1387.
Park EY, Lee KW, Lee HW, Cho YW, Baek NI, Chung HG, Jeong TS, Choi MS, and Lee KT (2008) The ethanol extract from Artemisia princeps Pampanini induces p53-mediated G1 Phase arrest in A172 human neuroblastoma cells. J Med Food 11, 237–245.
Pauli GF, Poetsch F, and Nahrstedt A (1998) Structure assignment of natural quinic acid derivatives using proton nuclear magnetic resonance techniques. Phytochem Analysis 9, 177–185.
Peluso G, De Feo V, De Simone F, Bresciano E, and Vuotto ML (1995) Studies on the inhibitory effects of caffeoylquinic acids on monocyte migration and superoxide anione production. J Nat Prod 58, 639–646.
Peyroux J and Sternberg M (2006) Advanced glycation end-products (ages): pharmacological inhibition in diabetes. Pathol Biol 54, 405–419.
Satake T, Kamiya K, An Y, Oishi Nee Taka T, and Yamamoto J (2007) The anti-thrombotic active constituents from Centella asiatica. Biol Pharm Bull 30, 935–940.
Sarath VJ, So CS, Won YD, and Gollapudi S (2007) Artemisia princeps var. orientalis induces apoptosis in human breast cancer MCF-7 cells. Anticancer Res 27, 3891–3798.
Shi S, Huang K, Zhang Y, Zhao Y, and Du Q (2007) Purification and identification of antiviral components from Laggera pterodonta by high-speed counter-current chromatography. J Chromatogr B 859, 119–124.
Timmermann BN, Hoffmann JJ, Jolad SD, Schram KH, Klenck RE, and Bates RB (1983) Constituents of Chrysothamnus paniculatus 3: 3,4,5-Tricaffeoylquinic Acid (a New Shikimate Prearomatic) and 3,4-, 3,5- and 4,5-Dicaffeoylquinic Acids. J. Nat. Prod 46, 365–368.
Tong S, Yan J, and Guan YX (2008) Preparative separation of isomeric caffeoylquinic acids from Flos Lonicerae by pH-zone-refining counter-current chromatography. J Chromatogr A 1212, 48–53.
Ureda H, Kuroiwa E, Tachibana Y, Kawanishi K, Ayala F, and Moriyasu M (2004) Aldose reductase inhibitors from the leaves of Myrciaria dubia (H.B.&K.) McVaugh. Phytomedicine 11, 652–656.
Vander Jagt DL (2008) Methylglyoxal, diabetes mellitus and diabetic complications. Drug Metabol Drug Interact 23, 93–124.
Yoshikawa M and Matsuda H (2006) In Traditional Medicines for Modern Times; Antidiabetic plants, Soumyanath A (ed.). CRC, Portland, OR, U.S.A.
Yoshimoto M, Yahara S, Okuno S, Islam MS, Ishiguro K, and Yamakawa O (2002) Antimutagenicity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweetpotato (Ipomoea batatas L.) leaf. Biosci Biotechnol Biochem 66, 2336–2341.
Zhao QC, Kiyohara H, and Yamada H (1994) Anti-complementary neutral polysaccharides from leaves of Artemisia princeps. Phytochemistry 35, 73–77.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Cui, CB., Jeong, S.K., Lee, Y.S. et al. Inhibitory activity of caffeoylquinic acids from the aerial parts of Artemisia princes on rat lens aldose reductase and on the formation of advanced glycation end products. J. Korean Soc. Appl. Biol. Chem. 52, 655–662 (2009). https://doi.org/10.3839/jksabc.2009.109
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.3839/jksabc.2009.109
Key words
- advanced glycation end products
- Artemisia princes
- caffeoylquinic acids
- rat lens aldose reductase